Tugbainanc (Talk | contribs) |
|||
(67 intermediate revisions by 4 users not shown) | |||
Line 14: | Line 14: | ||
</header> | </header> | ||
− | <section class="ct-u- | + | <section class="ct-u-paddingBoth50"> |
<div class="container"> | <div class="container"> | ||
− | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/7/72/T--METU_HS_Ankara--partsbanner.jpg" /> |
+ | <table class="table" style="font-size: 17px"> | ||
+ | <thead> | ||
+ | <tr> | ||
+ | <th>Name</th> | ||
+ | <th>Type</th> | ||
+ | <th>Description</th> | ||
+ | <th>Designer</th> | ||
+ | <th>Length</th> | ||
+ | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
+ | <tr class="danger"> | ||
+ | <td><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">BBa_K2571003</a></td> | ||
+ | <td><img width="80" src="https://static.igem.org/mediawiki/2018/b/b5/T--METU_HS_Ankara--cparts01.jpg" /></td> | ||
+ | <td>FucO / L-1,2-propanediol oxidoreductase</td> | ||
+ | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
+ | <td>1350 bp</td> | ||
+ | </tr> | ||
+ | <tr class="warning" style="font-size: 17px; color: #000000"> | ||
+ | <td><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a></td> | ||
+ | <td><img width="80" src="https://static.igem.org/mediawiki/2018/b/b5/T--METU_HS_Ankara--cparts01.jpg" /></td> | ||
+ | <td>GSH/ Bifunctional gamma-glutamate-cysteine ligase/Glutathione synthetase</td> | ||
+ | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
+ | <td>2466 bp</td> | ||
+ | </tr> | ||
+ | <tr class="info"> | ||
+ | <td><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571006">BBa_K2571006</a></td> | ||
+ | <td><img width="80" src="https://static.igem.org/mediawiki/2018/b/b5/T--METU_HS_Ankara--cparts01.jpg" /></td> | ||
+ | <td>Dual Expression of FucO and GSH</td> | ||
+ | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
+ | <td>3644 bp</td> | ||
+ | </tr> | ||
+ | </tbody> | ||
+ | </table> | ||
<h3>Composite Part 1:</h3> | <h3>Composite Part 1:</h3> | ||
<h4>FucO/ L-1,2-Propanediol Oxidoreductase</h4> | <h4>FucO/ L-1,2-Propanediol Oxidoreductase</h4> | ||
<p> | <p> | ||
− | FucO is the gene that codes for L-1,2-propanediol oxidoreductase which is a NADH-linked, homodimer enzyme having the role | + | FucO is the gene that codes for L-1,2-propanediol oxidoreductase which is a NADH-linked, homodimer enzyme having the role of |
− | + | acting on furfural which is a toxic inhibitor of microbial fermentations causing cell wall and membrane damage, DNA breakdowns | |
− | + | and reduced enzymatic activities (Zheng, 2013; Liu, Ma & Song, 2009). | |
</p> | </p> | ||
<p> | <p> | ||
The enzyme catalyzes L-lactaldehyde and L-1,2- propanediol while dissimilating fucose in which acetaldehyde, ethylene glycerol, | The enzyme catalyzes L-lactaldehyde and L-1,2- propanediol while dissimilating fucose in which acetaldehyde, ethylene glycerol, | ||
− | L-lactaldehyde and some more substances are used as substrates. Despite these, it takes an important role in furan reduction | + | L-lactaldehyde and some more substances are used as substrates. Despite these, it takes an important role in furan reduction |
− | its alcohol derivative (Wang et al., 2011). | + | to its alcohol derivative (Wang <i>et al.</i>, 2011). |
</p> | </p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/7/70/T--METU_HS_Ankara--cparts06.jpg" /> | ||
<h5>Our circuit design for FucO gene</h5> | <h5>Our circuit design for FucO gene</h5> | ||
<p> | <p> | ||
Our circuit consists of prefix, a strong promoter (J23100), RBS (B0034), FucO as protein coding region, double terminator (B0015) | Our circuit consists of prefix, a strong promoter (J23100), RBS (B0034), FucO as protein coding region, double terminator (B0015) | ||
− | and suffix. This part enables our E. coli KO11 strain to convert toxic furfural into furfuryl alcohol. Our construct | + | and suffix. This part enables our <i>E. coli</i> KO11 strain to convert toxic furfural into furfuryl alcohol. Our construct was inserted |
into pSB1C3 and delivered to the Registry. | into pSB1C3 and delivered to the Registry. | ||
</p> | </p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/0/03/T--METU_HS_Ankara--cparts02.jpg" /> | ||
+ | <br /> | ||
+ | <i class="parts-info"> | ||
+ | Figure 1: Circuit design of Composite part 1 with FucO gene. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">BBa_K2571003.</a> | ||
+ | Our construct includes a strong promoter, RBS, FucO and double terminator. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | In order to make our gene compatible with RFC 10, 25 and 1000, we reconstructed the nucleotides to get rid of the restriction sites while protecting | |
− | + | the amino acid sequence. We looked through the codon bias property of <i>E. coli</i> and made the nucleotide changes accordingly. | |
− | + | ||
</p> | </p> | ||
<p> | <p> | ||
− | + | FucO has NADH-dependent furan reductase activity. When furfural is present in the field, the metabolism of furfural by NADPH-dependent oxidoreductases | |
− | + | goes active in order to reduce it to its less toxic alcohol derivative-furfuryl alcohol (Zheng, 2013; Wang <i>et al.</i>, 2013; Allen <i>et al.</i>, 2010). | |
</p> | </p> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/0/0c/T--METU_HS_Ankara--cparts0121566415.jpg" /> | ||
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 2: Effect of FucO overexpression in LY180 (Wang <i>et al.</i>, 2011). The cell mass was observed in furfural containing medium. The FucO gene expressing | ||
+ | L-1,2-propanediol oxidoreductase reduces the effect of furfural. The specific death rate of normal bacteria is observed to be higher than the specific | ||
+ | death rate of bacteria with FucO gene. Thus, FucO is shown to increase the tolerance and lifespan of bacteria. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | In this metabolism, the expression of oxidoreductases that are NADPH-dependent, such as YqhD, are shown to inhibit the growth and fermentation in <i>E. coli</i> | |
− | + | by competing for biosynthesis with NADPH (Zheng, 2013). | |
− | + | ||
− | + | ||
</p> | </p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts04.jpg" /> | ||
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 3: The overexpression of FucO and YqhD and relationships with furfural resistance traits, metabolism, and reducing cofactors (Wang <i>et al.</i>, 2013). | ||
+ | </i> | ||
<p> | <p> | ||
− | + | Because the native conversion of NADH to NADPH in <i>E. coli</i> is insufficient to revitalize the NADPH pool during fermentation, the actions shouldn’t be | |
− | (Wang et al., | + | interfering with NADPH metabolism (Wang <i>et al.</i>, 2011). Thus, the overexpression of plasmid-based NADH-dependent propanediol oxidoreductase (FucO) gene |
+ | reduces furfural to ultimately improve furfural resistance without detrimentally affecting the biosynthesis of NADPH (Wang <i>et al.</i>, 2011). | ||
</p> | </p> | ||
+ | |||
+ | <img width="500" src="https://static.igem.org/mediawiki/2018/b/be/T--METU_HS_Ankara--cparts05.gif" /> | ||
+ | <br> | ||
+ | <i class="parts-info" style="margin-bottom: 20px"> | ||
+ | Figure 4: 3D protein structure of L-1,2-propanediol oxidoreductase. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | The protein structure of L-1,2-propanediol oxidoreductase was constructed by using Amber 14. It is demonstrated in ribbon diagram which is done by interpolating a smooth curve through the polypeptide backbone. The colors indicate the amino acids in the protein structure. | |
− | + | ||
</p> | </p> | ||
+ | |||
+ | <div class="col-md-6" style="margin-bottom: 30px"> | ||
+ | <img width="500" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | ||
+ | <br> | ||
+ | <i class="parts-info" style="line-height: 0px !important"> | ||
+ | Figure 5: BBa_K2571003 check with FucO left and VR primers. Expected band length: 754 bp. Last three wells show positive results. | ||
+ | </i> | ||
+ | </div> | ||
+ | |||
+ | <div class="col-md-6"> | ||
+ | <p> | ||
+ | We’ve inserted the FucO composite part to pSB1C3 and pSB1A3 backbones. Then, we’ve transformed the construct for submission, | ||
+ | <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">BBa_K2571003</a>, (in pSB1C3) | ||
+ | to DH5⍺; and the other construct, for our biochemical assay, (in pSB1A3) to KO11. As we isolated the plasmids, we’ve done PCR with FucO left and VR | ||
+ | primers to test orientation of our parts to the backbone. We expected a band of 754 bp between the FucO left and VR primers and the PCR results confirmed | ||
+ | our expectations and showed that our parts were correctly inserted and transformed. | ||
+ | </p> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
<p> | <p> | ||
− | + | FucO Left and VR primers are as below: | |
− | + | <br > | |
− | + | FucO Left: GTGATAAGGATGCCGGAGAA | |
− | VR | + | <br > |
+ | VR: ATTACCGCCTTTGAGTGAGC | ||
+ | |||
</p> | </p> | ||
<h3>Composite 2:</h3> | <h3>Composite 2:</h3> | ||
− | <h4>GSH:Bifunctional gamma-glutamate-cysteine ligase/ | + | <h4>GSH:Bifunctional gamma-glutamate-cysteine ligase/Glutathione synthetase</h4> |
<p> | <p> | ||
− | + | Reactive Oxygen Species (ROS) are dangerous substances that distort protein based matters by taking electrons (Lu, 2013). The chemical structure of the protein-based | |
− | + | substances are altered and become dysfunctional because of ROS (Lu, 2013; Burton & Jauniaux, 2011). | |
− | + | ||
</p> | </p> | ||
<p> | <p> | ||
− | + | Furthermore; one of the most significant protein-based substance, DNA, gets attacked by OH radicals (Burton & Jauniaux, 2011). However, the reduced form GSH can protect | |
− | + | the chemical structure of the proteins by donating extra electrons to ROS and free radicals (Lu, 2013). This is accomplished by GSH peroxidase-catalyzed reactions | |
+ | (Lu, 2013). | ||
</p> | </p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/7/70/T--METU_HS_Ankara--cparts0121566.jpg" /> | ||
+ | |||
+ | <img width="500" src="https://static.igem.org/mediawiki/2018/c/cd/T--METU_HS_Ankara--cparts08.gif" /> | ||
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 6: 3D protein structure of Bifunctional gamma-glutamate-cysteine ligase. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | The protein structure of Bifunctional gamma-glutamate-cysteine ligase was constructed by using Amber 14. It is demonstrated in ribbon diagram which is done by interpolating a smooth curve through the polypeptide backbone. The colors indicate the amino acids in the protein structure. | |
− | + | ||
− | + | ||
</p> | </p> | ||
+ | |||
+ | <h5>Our circuit design for GSH gene</h5> | ||
<p> | <p> | ||
− | + | Our circuit consists of prefix, a strong promoter (J23100), RBS (B0034), GSH as protein coding region, double terminator (B0015) and suffix. This part enables our <i>E. coli</i> KO11 strain to overexpress oxidised Glutathione to reduce oxidative stress, increasing its lifespan (Lu, 2013). Our construct was inserted into pSB1C3 and | |
− | + | delivered to the Registry. | |
</p> | </p> | ||
− | < | + | <img src="https://static.igem.org/mediawiki/2018/b/b4/T--METU_HS_Ankara--cparts09.jpg" /> |
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 7: Circuit design of Composite part 2 with GSH gene. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a>. Our construct | ||
+ | includes a strong promoter, RBS, GSH and double terminator. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | In order to make our gene compatible with RFC 10, 25 and 1000, we reconstructed the nucleotides to get rid of the restriction sites while protecting the amino acid | |
− | + | sequence. We looked through the codon bias property of <i>E. coli</i> and made the nucleotide changes accordingly. | |
− | + | ||
</p> | </p> | ||
− | < | + | <img src="https://static.igem.org/mediawiki/2018/8/87/T--METU_HS_Ankara--cparts012566.jpg" /> |
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 8: Because Glutathione prevents ROS from harming the bacteria, increase in cell mas was observed in high concentrations of Glutathione. In brief, when | ||
+ | Glutathione concentration increases, the specific cell growth rate also increases and we observe an increase in the number of bacteria compared to the bacteria without | ||
+ | the GSH gene (Kim & Hahn , 2013). | ||
+ | </i> | ||
+ | <div class="col-md-6"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> | ||
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 9: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a> check with GSH specific primers. Expected band length: 225 bp. | ||
+ | Last six wells show positive results. | ||
+ | </i> | ||
+ | </div> | ||
+ | |||
+ | <div class="col-md-6"> | ||
+ | <p> | ||
+ | We’ve inserted the GSH composite part to pSB1C3 backbone. Then, we’ve transformed the construct for submission, | ||
+ | <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a>, (in pSB1C3) | ||
+ | to Dh4 alpha and conducted colony PCR. We’ve prepared the PCR with GSH specific primers and expected to see a result of 225 bp. By showing the | ||
+ | band we expected, 225 bp, PCR confirmation for our insertion proved right. | ||
+ | </p> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
<p> | <p> | ||
− | + | GSH left and right primers are shown as below: | |
− | < | + | <br > |
− | + | GSH left: TCGGAGGCTAAAACTCAGGA | |
− | + | <br > | |
+ | GSH right: GTGGGCAGTCCAGTCGTAAT | ||
</p> | </p> | ||
Line 122: | Line 241: | ||
The first protein coding region we have, placed after the RBS, FucO, will code for L-1,2-propanediol oxidoreductase (a homodimer enzyme) | The first protein coding region we have, placed after the RBS, FucO, will code for L-1,2-propanediol oxidoreductase (a homodimer enzyme) | ||
in order to act upon furfural presence in the field (Zheng, 2013). The metabolism of furfural by NAD(P)H-dependent oxidoreductases will | in order to act upon furfural presence in the field (Zheng, 2013). The metabolism of furfural by NAD(P)H-dependent oxidoreductases will | ||
− | reduce the toxicity of the chemical by turning it into furfuryl alcohol, | + | reduce the toxicity of the chemical by turning it into a derivative, furfuryl alcohol, and increase the furfural tolerance (Zheng, 2013; |
− | Wang et al., 2013; Allen et al., 2010). Our second protein coding region, bifunctional gamma-glutamate-cysteine ligase/ | + | Wang <i>et al.</i>, 2013; Allen <i>et al.</i>, 2010). Our second protein coding region, bifunctional gamma-glutamate-cysteine ligase/Glutathione |
synthetase (GSH), is a non-protein thiol group and a tripeptide composed of cysteine, glycine and glutamic acid (Lu, 2013). It is crucial | synthetase (GSH), is a non-protein thiol group and a tripeptide composed of cysteine, glycine and glutamic acid (Lu, 2013). It is crucial | ||
− | for the detoxification of reactive oxygen species and free radicals (Ask et al | + | for the detoxification of reactive oxygen species and free radicals (Ask <i>et al.</i> 2013). Reactive oxygen species (ROS) are harmful substances |
that alter protein based matters by taking electrons (Lu, 2013; Burton & Jauniaux, 2011). Because many benefits of GSH include scavenging | that alter protein based matters by taking electrons (Lu, 2013; Burton & Jauniaux, 2011). Because many benefits of GSH include scavenging | ||
− | of ROS, protection against endogenous toxic metabolites and detoxification of xenobiotics, we choose this gene to | + | of ROS, protection against endogenous toxic metabolites and detoxification of xenobiotics, we choose this gene to integrate with FucO |
− | (Höck et al., 2013). Thus we constructed multi functional gene providing long life span and resistance. | + | (Höck <i>et al.</i>, 2013). Thus we constructed a multi-functional gene providing long life span and resistance. |
</p> | </p> | ||
− | <h4>Design Notes of Dual Expression of FucO and GSH</h4> | + | <h4>Design Notes of Dual Expression of FucO and GSH <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571006">(BBa_K2571006)</a></h4> |
<p> | <p> | ||
− | Our construct for composite part 3 is composed of two stages, first the reduction of furans (specifically furfural and 5-HMF) and second | + | Our construct for composite part 3 is composed of two stages, first the reduction of furans (specifically furfural and 5-HMF) and second the |
− | + | detoxification of reactive oxygen species (ROS). To achieve this effect, we designed our composite 3 part as with a prefix, a strong promoter | |
− | + | (J23100), RBS (B0034), FucO as the first protein coding region <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">(BBa_K2571003)</a>, | |
− | + | RBS (B0034), GSH as the second protein coding region <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">(BBa_K2571005)</a>, | |
+ | double terminator (B0015) and suffix. | ||
</p> | </p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/d/dc/T--METU_HS_Ankara--cparts01256eie6.jpg" /> | ||
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 10: Circuit design of Composite part 3 with FucO and GSH genes. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571006">BBa_K2571006</a>. | ||
+ | Our construct includes a strong promoter, RBS, FucO, RBS, GSH and double terminator. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | Our construct was inserted into pSB1C3 and delivered to the Registry. Our construct was also inserted into pSB1A3 and transferred into KO11 to | |
− | + | conduct further biochemical assays. | |
− | + | ||
− | + | ||
</p> | </p> | ||
− | < | + | <p> |
+ | Given that FucO is NADH-dependent, it outperforms other oxidoreductases by not interfering with the NADPH metabolism of the organism while converting highly | ||
+ | toxic substances, furfural and 5-HMF to non-harmful alcohols. This characteristic of FucO is crucial because the expression of oxidoreductases like Yqhd are | ||
+ | NADPH-dependent, hence they compete with the biosynthesis for NADPH, which results in inhibiting the growth of the organism. | ||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | Glutathione, on the other hand, is recycled using NAD(P)H pathways and since its over-expression with NADH metabolism not being altered thanks | ||
+ | to FucO, antioxidant capacity of the cell will be increased dramatically; resulting in amplified immunity to both furans and ROS, habilitated cell growth and | ||
+ | increased ethanol yield by the virtue of increasing cell mass and reproduction, and improved metabolism. | ||
+ | </p> | ||
+ | |||
+ | <h3>Gel Results</h3> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | ||
+ | <i class="parts-info"> | ||
+ | Figure 11: BBa_K2571006 check with GSH and FucO specific primers. Expected band length: 194 bp. Green boxes show positive results. | ||
+ | </i> | ||
+ | |||
+ | <p> | ||
+ | We’ve inserted our composite part 3(BBa_K2571006) in both pSB1C3 and pSB1A3 backbones. The construct in pSB1C3 is for submission to registry and is cultivated | ||
+ | in DH5 alpha. The plasmid having pSB1A3 as backbone, thus carrying ampicillin resistance is for our biochemical assays since we’ve chosen the chassis organism | ||
+ | for assays as E.coli strain KO11 which already has Chloramphenicol resistance in its genome. After cloning our genes, we’ve made colony PCR to verify our insertions. | ||
+ | We chose the primers as FucO specific since the composite 3 contains FucO coding region. Expected band length was 194 bp, and as expected, the bands were given by all | ||
+ | of the DH5 alpha and KO11 colonies we chose, confirming our transformations. | ||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | FucO specific primers were used:<br> | ||
+ | FucO left: GTGATAAGGATGCCGGAGAA<br> | ||
+ | FucO right: CTTCTCGCCGGTAAAGTCAG<br> | ||
+ | </p> | ||
+ | |||
+ | |||
<div class="container"> | <div class="container"> | ||
<div class="row"> | <div class="row"> | ||
− | <div class="col-md- | + | <div class="col-md-12"> |
<div class="panel-group" id="accordion"> | <div class="panel-group" id="accordion"> | ||
<div class="panel panel-default"> | <div class="panel panel-default"> | ||
Line 160: | Line 318: | ||
</h4> | </h4> | ||
</div> | </div> | ||
− | <div id="collapseOne" class="panel-collapse collapse | + | <div id="collapseOne" class="panel-collapse collapse"> |
<div class="panel-body"> | <div class="panel-body"> | ||
− | Allen, S. A., Clark, W., McCaffery, J. M., Cai, Z., Lanctot, A., Slininger, P. J., | + | <ul> |
− | + | <li> | |
− | + | <strong>Allen, S. A., Clark, W., McCaffery, J. M., Cai, Z., Lanctot, A., Slininger, P. J., Gorsich, S. W.</strong> | |
+ | (2010). Furfural induces reactive oxygen species accumulation and cellular damage in Saccharomyces cerevisiae. Biotechnology for Biofuels, 3, 2. | ||
+ | <a href="http://doi.org/10.1186/1754-6834-3-2">http://doi.org/10.1186/1754-6834-3-2</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Burton, G. J., & Jauniaux, E.</strong> | ||
+ | (2011). Oxidative stress. Best Practice & Research. Clinical Obstetrics & Gynaecology, 25(3), 287–299. | ||
+ | <a href="http://doi.org/10.1016/j.bpobgyn.2010.10.016">http://doi.org/10.1016/j.bpobgyn.2010.10.016</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Chou, H.-H., Marx, C. J., & Sauer, U.</strong> | ||
+ | (2015). Transhydrogenase Promotes the Robustness and Evolvability of E. coli Deficient in NADPH Production. PLoS Genetics, 11(2), e1005007. | ||
+ | <a href="http://doi.org/10.1371/journal.pgen.1005007">http://doi.org/10.1371/journal.pgen.1005007</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Lu, S. C.</strong> | ||
+ | (2013). Glutathione Synthesis. Biochemica et Biophysica Acta, 1830(5), 3143–3153. | ||
+ | <a href="http://doi.org/10.1016/j.bbagen.2012.09.008">http://doi.org/10.1016/j.bbagen.2012.09.008</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Liu, Z.L., Ma M., Song, M.</strong> | ||
+ | (2009). Evolutionarily engineered ethanologenic yeast detoxifies lignocellulosic biomass conversion inhibitors by reprogrammed pathways. Mol Genet Genomics 282, 233-244. | ||
+ | <a href="http://doi.org/10.1007/s00438-009-0461-7">http://doi.org/10.1007/s00438-009-0461-7</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>National Center for Biotechnology Information.</strong> | ||
+ | PubChem Compound Database; CID=124886, | ||
+ | <a href="https://pubchem.ncbi.nlm.nih.gov/compound/124886">https://pubchem.ncbi.nlm.nih.gov/compound/124886</a> | ||
+ | (accessed July 18, 2018). | ||
+ | <a href="https://pubchem.ncbi.nlm.nih.gov/compound/124886#section=Top">https://pubchem.ncbi.nlm.nih.gov/compound/124886#section=Top</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Pizzorno, J.</strong> | ||
+ | (2014). Glutathione! Integrative Medicine: A Clinician’s Journal, 13(1), 8–12. | ||
+ | <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684116/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684116/</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Wang, X., Miller, E. N., Yomano, L. P., Zhang, X., Shanmugam, K. T., & Ingram, L. O.</strong> | ||
+ | (2011). Increased Furfural Tolerance Due to Overexpression of NADH-Dependent Oxidoreductase FucO in Escherichia coli Strains Engineered | ||
+ | for the Production of Ethanol and Lactate. Applied and Environmental Microbiology, 77(15), 5132–5140. | ||
+ | <a href="http://doi.org/10.1128/AEM.05008-11">http://doi.org/10.1128/AEM.05008-11</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Wang, X & N Miller, E & Yomano, Lorraine & Zhang, Xueli & T Shanmugam, K & Ingram, Lonnie.</strong> | ||
+ | ((2011). Increased Furfural Tolerance Due to Overexpression of NADH-Dependent Oxidoreductase FucO in Escherichia coli Strains Engineered | ||
+ | for the Production of Ethanol and Lactate. Applied and environmental microbiology. | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Xuan Wang, Lorraine P. Yomano, James Y. Lee, Sean W. York, Huabao Zheng,Michael T. Mullinnix, K. T. Shanmugam, and Lonnie O. Ingram,</strong> | ||
+ | (2013), Engineering furfural tolerance in Escherichia coli improves the fermentation of lignocellulosic sugars into renewable chemicals. | ||
+ | <a href="https://doi.org/10.1073/pnas.1217958110">https://doi.org/10.1073/pnas.1217958110</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Zheng, H., Wang, X., Yomano, L.P., Geddes, R. D, Shanmugan, K. T., Ingram, L.O.</strong> | ||
+ | (2013). Improving Escherichia coli FucO for Furfural Tolerance by Saturation Mutagenesis of Individual Amino Acid Positions. | ||
+ | Applied and Environmental Microbiology Vol 79, no 10.3202–3208. | ||
+ | <a href="http://aem.asm.org/content/79/10/3202.full.pdf+html">http://aem.asm.org/content/79/10/3202.full.pdf+html</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <strong>Kim, D., & Hahn, J.-S.</strong> | ||
+ | (2013). Roles of the Yap1 Transcription Factor and Antioxidants in Saccharomyces cerevisiae’s Tolerance to Furfural and 5-Hydroxymethylfurfural, | ||
+ | Which Function as Thiol-Reactive Electrophiles Generating Oxidative Stress. Applied and Environmental Microbiology, 79(16), 5069–5077. | ||
+ | <a href="http://doi.org/10.1128/AEM.00643-13">http://doi.org/10.1128/AEM.00643-13</a> | ||
+ | </li> | ||
+ | </ul> | ||
+ | |||
</div> | </div> | ||
</div> | </div> | ||
Line 175: | Line 398: | ||
</div> | </div> | ||
− | |||
</html> | </html> | ||
{{METU_HS_Ankara/footer}} | {{METU_HS_Ankara/footer}} |
Latest revision as of 15:13, 17 October 2018